Table 1.
Deletions | Mouse
|
Human
|
|||
---|---|---|---|---|---|
PK/c-myc | WHV/c-myc | PK/H-ras | Samples | Cell lines§ | |
m exon 2 (aa 12-37)* | 1/30 | ||||
m exon 2 (aa 19-74)* | 1/30 | ||||
m exon 2 (aa 5-80)*† | 9/30 | 2/20 | 3/11 | ||
m exons 2-4 (aa 22-172)* | 1/30 | ||||
m exons 2-5 (aa 32-249)* | 1/11 | ||||
h exons 3-4 (aa 25-140)* | HepG2 | ||||
h exons 3-4 (aa 20-151)* | 1/26 | ||||
Point mutations | |||||
D32N | D32V, D32Y | ||||
S33C, S33Y | S33F | ||||
G34V | G34V (2)‡, G34E | G34E | G34V(HuH6) | ||
S37P | S37F | S37Y | |||
T41A | T41I (2)‡ | ||||
S45P | |||||
Total mutations | 17/30 | 10/20 | 4/11 | 6/26 | 2/5 |
The exon encoding the GSK-3β phosphorylation site is exon 2 for the mouse (m) and exon 3 for human (h).
Amino acid deleted according to mRNA analysis.
m exon 2 encodes aa 5-80 in the mouse β-catenin gene.
Mutations detected on two independent tumors.
The different cell lines tested were the HepG2, HuH6, PLC/PRF/5, Hep3B, and Huh7.